Announcements Trials
Browse Landscape

Phase

Phase NA 112Phase 2 9Phase 3 7Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 4Neoplasms 2Weight Loss 1Myasthenia Gravis 1Lung Neoplasms 1Leukemia 1Gynecologic Cancer 1Gastrointestinal Neoplasms 1Cardiotoxicity 1Cachexia 1Breast Neoplasms 1

Interventions

Paclitaxel 81Trastuzumab 76Fulvestrant 55Cyclophosphamide 49Capecitabine 42Lapatinib 40pembrolizumab 38Docetaxel 38palbociclib 36Carboplatin 32Letrozole 28olaparib 23Doxorubicin 23Gemcitabine 21Taxes 20Everolimus 20ribociclib 19abemaciclib 19Ado-Trastuzumab Emtansine 18pertuzumab 17Radiotherapy 17Magnetic Resonance Spectroscopy 17Bevacizumab 16130-nm albumin-bound paclitaxel 16exemestane 15Vinorelbine 15Cisplatin 15veliparib 14Biopsy 14Alpelisib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Breast Neoplasms × Exercise × Clear all
NCT02006979 2019-10-25

Acute Exercise Cardioprotection From Doxorubicin

University of British Columbia

Phase 1 Completed
27 enrolled 18 charts
Breast

Breast Neoplasms, Motor Activity, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡